Galderma Receives FDA Approval for Restylane Kysse
Posted By American Med Spa Association, Tuesday, May 5, 2020
Galderma has announced that the U.S. Food and Drug Administration (FDA) has approved Restylane Kysse for lip augmentation and the correction of upper perioral rhytids (wrinkles around upper lips) in adults over the age of 21. Restylane Kysse is the first hyaluronic acid (HA) filler specifically indicated for the lips using XpresHAn Technology, globally referred to as the Optimal Balance Technology. Restylane Kysse is proven to last for up to one year with high levels of patient satisfaction for people with lips that have changed due to the aging process or for those seeking natural-looking, fuller lips.
Read more at PR Newswire >>
Read more at PR Newswire >>